Le Lézard
Classified in: Health
Subjects: PSF, STP, SCZ

Latex Safety Events Stretch Far Beyond Gloves

HARRISBURG, Pa., March 22, 2018 /PRNewswire-USNewswire/ -- Maintaining a latex-safe healthcare environment can be a challenge for healthcare facilities. Despite the decreasing incidence of latex allergies, the potential for significant patient harm remains.

Courtesy of Shutterstock

"The correlation between latex allergies and gloves has become so intertwined, that other threats in healthcare environments that exist for those who have a latex allergy can be overlooked," said Dr. Ellen S. Deutsch, medical director for the Pennsylvania Patient Safety Authority. "Reactions from latex allergies can be life threatening safety events; identifying products that contain latex and assessing the risk for patient harm is essential."   

Analysis of latex-related events reported to the Authority between 2014 and 2016 identified 616 events. Those 616 events consisted of 72 "near misses" (events that might have caused harm but did not reach the patient), 537 exposure events (breaches in latex precautions that reached the patient), and 7 Serious Events (events resulting in patient harm).

Latex indwelling catheters were the most common source of unintended latex exposure (75%, n= 408 of 544). An additional thirty-five unique latex containing products were mentioned in event narratives, most notably gloves, Penrose drains, and red rubber catheters. The majority of both exposure and near miss events occurred in perioperative care areas (57.1%, n= 352 of 616).

Event narratives revealed (1) a variety of contributing factors for latex exposure events and (2) success modes for prevention. Lack of communication, poor documentation, and ineffective product management all contributed to unintended latex exposure events. Conversely, success modes for prevention included thorough patient assessments, acute observation of missing allergy wristbands, and handoff communication.

"It can be exciting when risk reduction strategies regarding a complex patient safety challenge, such as latex allergies, have been successful," says Deutsch. We must be careful not to forget that risk reduction is not eradication; there is still a small, but significant population that remains at risk for patient harm."  

In the Authority's March 2018 Pennsylvania Patient Safety Advisory article, "Latex: A Lingering and Lurking Safety Risk," the Authority discusses latex allergy exposures and strategies for prevention. A standalone graphic further highlights the important factors in protecting patients with latex allergies.

Download the full article.

Also published in this Advisory:

For more information about the Authority, patient safety topics, Advisory articles, and safety tips for patients, please visit patientsafety.pa.gov.

The Authority's mission is to improve the quality of healthcare in Pennsylvania by collecting and analyzing patient safety information, developing solutions to patient safety issues, and sharing this information through education and collaboration. Its vision is safe healthcare for all patients.

Like the Authority on Facebook
Subscribe to the Authority on YouTube
Follow the Authority on Twitter
Connect with the Authority on LinkedIn

Pennsylvania Patient Safety Authority - Visual Abstract:  Sustaining Risk Reduction Strategies to Protect Patients with Latex Allergies

SOURCE Pennsylvania Patient Safety Authority

These press releases may also interest you

at 04:00
January 28, 2022 Major German University Hospital secures long-term access to the latest health technology through renewal of diagnostic and image-guided therapy solutionsPhilips to deliver new and upgraded hybrid operating room and interventional...

at 03:10
Warriors Heart has been recognized by the 2022 Real Leaders Impact Awards for the third year in a row as one of the top social impact companies in the world. Warriors Heart CEO/Founder Josh Lannon expressed gratitude, "We are grateful to be...

at 03:00
Shake That Weight, a supplier of weight loss products based in Stoke-on-Trent, has launched a new brand selling protein products called EatProtein. Their aim is to use their expertise to bring high quality protein products to the market and make...

at 03:00
Aurealis Therapeutics, a synthetic biology company developing groundbreaking four-in-one cell and gene therapies and Xbiome, an AI-based microbiome drug development company, today announced that the two companies have entered into an exclusive...

at 03:00
Micreos announced that it has appointed Joost Goderie to the management board as Chief Financial Officer (CFO). Joost will be working closely together with the other members of the management team to help drive Micreos's growth and deliver its...

at 03:00
NJ Top Docs has reviewed and approved Dr. Steven Georgesson, Dr. Jason O. Hall, Dr. Rachana Kulkarni, Dr. Chao-Tarng Cheng, Dr. Archana Patel, Dr. Ashok A. Patel, and Dr. Edward Rachofsky of Medicor Cardiology for 2021. Medicor Cardiology has been...

News published on 22 march 2018 at 10:58 and distributed by: